Company Overview
Snapshot
Founded in October 2010, QuickRing operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on the development of its patented technology for sutureless heart valve repair.
Business overview
QuickRing is a Health Tech & Life Sciences company developing a technology for sutureless heart valve repair procedures. Its core product is a patented system utilizing a proprietary stapler and smart staples to secure an annuloplasty ring, eliminating the need for traditional sutures. The company is primarily focused on sutureless mitral valve annuloplasty repair, addressing challenges faced by cardiac surgeons and enabling next-generation patient care, including minimally invasive and robotic approaches. QuickRing operates within the medical devices sector, targeting hospitals and surgeons.
Log in to access full profile ›Company Intelligence Q&A
- What is QuickRing's primary technological focus?
- QuickRing is developing a patented technology for sutureless heart valve repair, specifically focusing on mitral valve annuloplasty repair, which uses smart staples instead of sutures.
- What problem does QuickRing's technology aim to solve in cardiac surgery?
- QuickRing's technology aims to address the challenges faced by cardiac surgeons by enabling sutureless heart valve repair, facilitating minimally invasive approaches and fully robotic support for patient care.
- What is the current stage of QuickRing's product development?
- QuickRing's product is currently in the R&D stage, with a focus on advancing its sutureless heart valve repair system.
- When was QuickRing founded?
- QuickRing was founded in October 2010.
- What is QuickRing's business model?
- QuickRing operates on a B2B business model, targeting healthcare providers and the medical devices industry.